194 related articles for article (PubMed ID: 33235031)
1. A Systematic Review of Randomized Controlled Trials Comparing Renal Sympathetic Denervation Versus Sham Procedure for the Management of Uncontrolled Hypertension.
Maqsood MH; Rubab K; Anwar F; Afzal Khan MT; Maqsood MA; Farooq M; Tabaza L; Rangaswami J; Virk HUH
J Cardiovasc Pharmacol; 2021 Feb; 77(2):153-158. PubMed ID: 33235031
[TBL] [Abstract][Full Text] [Related]
2. Renal Denervation for Treating Hypertension: Current Scientific and Clinical Evidence.
Weber MA; Mahfoud F; Schmieder RE; Kandzari DE; Tsioufis KP; Townsend RR; Kario K; Böhm M; Sharp ASP; Davies JE; Osborn JW; Fink GD; Euler DE; Cohen DL; Schlaich MP; Esler MD
JACC Cardiovasc Interv; 2019 Jun; 12(12):1095-1105. PubMed ID: 31221299
[TBL] [Abstract][Full Text] [Related]
3. Renal Sympathetic Denervation: A Viable Option for Treating Resistant Hypertension.
Schlaich MP
Am J Hypertens; 2017 Sep; 30(9):847-856. PubMed ID: 28338871
[TBL] [Abstract][Full Text] [Related]
4. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
Worthley SG; Wilkins GT; Webster MW; Montarello JK; Delacroix S; Whitbourn RJ; Warren RJ
Atherosclerosis; 2017 Jul; 262():94-100. PubMed ID: 28531827
[TBL] [Abstract][Full Text] [Related]
5. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial.
Bhatt DL; Vaduganathan M; Kandzari DE; Leon MB; Rocha-Singh K; Townsend RR; Katzen BT; Oparil S; Brar S; DeBruin V; Fahy M; Bakris GL;
Lancet; 2022 Oct; 400(10361):1405-1416. PubMed ID: 36130612
[TBL] [Abstract][Full Text] [Related]
7. Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design.
Böhm M; Townsend RR; Kario K; Kandzari D; Mahfoud F; Weber MA; Schmieder RE; Tsioufis K; Hickey GL; Fahy M; DeBruin V; Brar S; Pocock S
Clin Res Cardiol; 2020 Mar; 109(3):289-302. PubMed ID: 32034481
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension.
Voora R; Hinderliter AL
Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545
[TBL] [Abstract][Full Text] [Related]
9. The REDUCE HTN: REINFORCE: Randomized, Sham-Controlled Trial of Bipolar Radiofrequency Renal Denervation for the Treatment of Hypertension.
Weber MA; Kirtane AJ; Weir MR; Radhakrishnan J; Das T; Berk M; Mendelsohn F; Bouchard A; Larrain G; Haase M; Diaz-Cartelle J; Leon MB
JACC Cardiovasc Interv; 2020 Feb; 13(4):461-470. PubMed ID: 32081240
[TBL] [Abstract][Full Text] [Related]
10. Resistant Hypertension and Renal Nerve Denervation.
Denker MG; Cohen DL
Methodist Debakey Cardiovasc J; 2015; 11(4):240-4. PubMed ID: 27057294
[TBL] [Abstract][Full Text] [Related]
11. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M
Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639
[TBL] [Abstract][Full Text] [Related]
12. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN).
Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P
Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691
[TBL] [Abstract][Full Text] [Related]
13. Catheter-Based Renal Denervation for Resistant Hypertension: Will It Ever Be Ready for "Prime Time"?
Laffin LJ; Bakris GL
Am J Hypertens; 2017 Sep; 30(9):841-846. PubMed ID: 27838622
[TBL] [Abstract][Full Text] [Related]
14. Late renal artery stenosis after percutaneous renal denervation.
Lambert T; Blessberger H; Grund M; Steinwender C
J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e169-e170. PubMed ID: 25090272
[TBL] [Abstract][Full Text] [Related]
15. Renal Denervation in the Management of Resistant Hypertension: A Comprehensive Review of Literature.
Salehin S; Karnkowska B; Hamza I; Malik H; Syeda D; Hasan SM; Rangasetty U; Gilani S; Jneid H; Raja M
Curr Probl Cardiol; 2024 Feb; 49(2):102137. PubMed ID: 37863457
[TBL] [Abstract][Full Text] [Related]
16. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
Fengler K; Ewen S; Höllriegel R; Rommel KP; Kulenthiran S; Lauder L; Cremers B; Schuler G; Linke A; Böhm M; Mahfoud F; Lurz P
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862930
[TBL] [Abstract][Full Text] [Related]
17. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
[TBL] [Abstract][Full Text] [Related]
18. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial.
Mahfoud F; Kandzari DE; Kario K; Townsend RR; Weber MA; Schmieder RE; Tsioufis K; Pocock S; Dimitriadis K; Choi JW; East C; D'Souza R; Sharp ASP; Ewen S; Walton A; Hopper I; Brar S; McKenna P; Fahy M; Böhm M
Lancet; 2022 Apr; 399(10333):1401-1410. PubMed ID: 35390320
[TBL] [Abstract][Full Text] [Related]
20. Challenging anatomy, how to treat or not to treat?
Zeller T; Rastan A; Macharzina R; Noory E
EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
